BioSpace News Archive

Business

The Caris Precision Oncology Alliance Welcomes University of Chicago Medicine Comprehensive Cancer Center

Caris Life Sciences announced today that the University of Chicago (UChicago) Medicine Comprehensive Cancer Center has joined the Caris Precision Oncology Alliance™ (POA).

March 8, 2023
·
5 min read
Business

AC Immune to Report Full Year 2022 Financial Results and Provide Corporate Update on March 16, 2023

AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that it will issue a press release to report its full year 2022 financial results and provide a corporate update on March 16, 2023 at 7:00am ET.

March 8, 2023
·
3 min read
BioMidwest

ONL Therapeutics Closes First Tranche of $15 Million Series C Financing to Advance Lead Compound into Phase 2 Clinical Trial

ONL Therapeutics, Inc. today announced it has closed on the first tranche of a $15 million Series C Preferred Stock financing round.

March 8, 2023
·
3 min read
BioForest

Athira Pharma to Present at Upcoming Neuroscience Focused Investor Conferences

Athira Pharma, Inc. today announced that members of Athira’s management team will participate in the following upcoming investor conferences: Needham Neurosciences Investor Forum taking place virtually March 15, 2023.

March 8, 2023
·
4 min read
Business

Galera Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Updates

Galera Therapeutics, Inc. today announced financial results for the fourth quarter and year ended December 31, 2022 and provided recent corporate updates.

March 8, 2023
·
12 min read
Drug Development

Sernova Announces Initial Islet Transplantation in First Two Patients Enrolled in Second Cohort of its U.S. Phase 1/2 Clinical Trial for Treatment of Type 1 Diabetes

Sernova Corp. announced today that the first two patients in the second cohort of its active U.S. Phase 1/2 clinical trial for the treatment of type 1 diabetes (“T1D”) and hypoglycemia unawareness received their first islet transplant into the higher capacity 10-channel Cell Pouch™.

March 8, 2023
·
5 min read
Biotech Bay

ASLAN Pharmaceuticals to Host Virtual Research and Development Day on Novel DHODH Inhibitor Farudodstat for Alopecia Areata

ASLAN Pharmaceuticals today announced that it will be hosting a virtual research and development day on Thursday, March 16, 2023, from 10:00 am – 11:30 am ET.

March 8, 2023
·
5 min read
Deals

BridgeBio Pharma Announces Pricing of Public Offering of Common Stock

BridgeBio Pharma, Inc. today announced the pricing on March 7, 2023 of an underwritten public offering of 8,823,530 shares of its common stock at a public offering price of $17.00 per share, before deducting underwriting discounts and commissions.

March 8, 2023
·
4 min read
Deals

Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2023

Zimmer Biomet Holdings, Inc. today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2023.

March 8, 2023
·
1 min read
Bio NC

UBC Selects THREAD to Launch New SitePlus Offering and Optimize Evidence Generation

United BioSource LLC, a leading provider of evidence development services, and THREAD, a decentralized research and consulting services provider, announced the launch of SitePlus.

March 8, 2023
·
3 min read